Toll-Like Receptor 4 Promotes NO Synthesis by Upregulating GCHI Expression under Oxidative Stress Conditions in Sheep Monocytes/Macrophages

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Deng, Shoulong ^a   Yu, Kun ^b   Zhang, Baolu ^b   Yao, Yuchang ^c   Wang, Zhixian ^b   Zhang, Jinlong ^d   Zhang, Xiaosheng ^d   Liu, Guoshi ^b   Li, Ning ^b   Liu, Yixun ^a   Lian, Zhengxing ^b  

^a INSTITUTE OF ZOOLOGY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^d Tianjin Institute of Animal Science   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BODY FLUIDS; FREE RADICALS; NITRIC OXIDE; REACTION INTERMEDIATES;

GRAM-NEGATIVE BACTERIA; GUANOSINE TRIPHOSPHATE; INFLAMMATORY RESPONSE; INNATE IMMUNE SYSTEMS; NITRIC-OXIDE SYNTHASE (INOS); OXIDATIVE ENVIRONMENT; RATE-LIMITING ENZYMES; TOLL-LIKE RECEPTOR 4;

OXIDATIVE STRESS;

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; INOSINATE DEHYDROGENASE INHIBITOR; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TETRAHYDROBIOPTERIN; TOLL LIKE RECEPTOR 4; ACETOPHENONE DERIVATIVE; APOCYNIN; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SYNTHESIS; TRANSGENIC SHEEP; UPREGULATION; ANIMAL; BLOOD; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; SHEEP; TRANSGENIC ANIMAL;

ACETOPHENONES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GTP CYCLOHYDROLASE; LIPOPOLYSACCHARIDES; MACROPHAGES; MALONDIALDEHYDE; MONOCYTES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SHEEP; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84947996741     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/359315     Document Type: Article

References (45)

1. L. Hoareau, K. Bencharif, P. Rondeau et al., "Signaling pathways involved in LPS induced TNFalpha production in human adipocytes," Journal of Inflammation, vol. 7, article 1, 2010.
2. K.-H. Tse, K. B. S. Chow, W. K. Leung, Y. H. Wong, and H. Wise, "Lipopolysaccharide differentially modulates expression of cytokines and cyclooxygenases in dorsal root ganglion cells via Toll-like receptor-4 dependent pathways," Neuroscience, vol. 267, pp. 241-251, 2014.
3. K. A. Ryan, M. F. Smith Jr., M. K. Sanders, and P. B. Ernst, "Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression," Infection and Immunity, vol. 72, no. 4, pp. 2123-2130, 2004.
4. K. Uchimura, M. Hayata, T. Mizumoto et al., "The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling," Nature Communications, vol. 5, article 3428, 2014.
5. O. O. Zaitseva, T. V. Polezhaeva, A. N. Khudyakov et al., "Influence of pectins on NADPH oxidase and phagocytic activity of neutrophils during cryopreservation," Cryo-Letters, vol. 34, no. 5, pp. 544-548, 2013.
6. S. Pacquelet, J. L. Johnson, B. A. Ellis et al., "Cross-talk between IRAK-4 and the NADPH oxidase," Biochemical Journal, vol. 403, no. 3, pp. 451-461, 2007.
7. K. A. Gauss, L. K. Nelson-Overton, D.W. Siemsen, Y. Gao, F. R. DeLeo, and M. T. Quinn, "Role of NF-κB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-α," Journal of Leukocyte Biology, vol. 82, no. 3, pp. 729-741, 2007.
8. Y. Suzuki, K. Hattori, J. Hamanaka et al., "Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia," Scientific Reports, vol. 2, article 896, 2012.
9. I.-T. Lee, R.-H. Shih, C.-C. Lin, J.-T. Chen, and C.-M. Yang, "Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells," Cell Communication and Signaling, vol. 10, no. 1, article 33, 2012.
10. Y. Y. Choi, M. H. Kim, J.M. Han et al., "The anti-inflammatory potential of Cortex Phellodendron in vivo and in vitro: downregulation of NO and iNOS through suppression of NF-κB and MAPK activation," International Immunopharmacology, vol. 19, no. 2, pp. 214-220, 2014.
11. M. Ohtsuki, T. Nomura, S.-I. Morimoto et al., "Suppressed expression of GTP cyclohydrolase I mRNA and accelerated expression of inducible nitric oxide synthase mRNA in endomyocardial biopsy specimens from patients with dilated cardiomyopathy," ClinicaChimicaActa, vol. 353, no. 1-2, pp. 103-107, 2005.
12. J.-Y. Lee, H. J. Yang, J.-M. Kim, and B. S. Jeon, "Novel GCH-1 mutations and unusual long-lasting dyskinesias in Korean families with dopa-responsive dystonia," Parkinsonism & Related Disorders, vol. 19, no. 12, pp. 1156-1159, 2013.
13. T. Jilling, D. Simon, J. Lu et al., "The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis," The Journal of Immunology, vol. 177, no. 5, pp. 3273-3282, 2006.
14. E. Faure, O. Equils, P. A. Sieling et al., "Bacterial lipopolysaccharide activates NF-κB through toll-like receptor 4 (TLR- 4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells," Journal of Biological Chemistry, vol. 275, no. 15, pp. 11058-11063, 2000.
15. E. Seki, H. Tsutsui, H. Nakano et al., "Lipopolysaccharideinduced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β," The Journal of Immunology, vol. 166, no. 4, pp. 2651-2657, 2001.
16. L.M. Haynes, D. D. Moore, E. A. Kurt-Jones, R.W. Finberg, L. J. Anderson, and R. A. Tripp, "Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus," Journal of Virology, vol. 75, no. 22, pp. 10730-10737, 2001.
17. M.-F. Roy, L. Larivière, R. Wilkinson, M. Tam, M. M. Stevenson, and D. Malo, "Incremental expression of Tlr4 correlates with mouse resistance to Salmonella infection and fine regulation of relevant immune genes," Genes and Immunity, vol. 7, no. 5, pp. 372-383, 2006.
18. S. Deng, Q. Wu, K. Yu et al., "Changes in the relative inflammatory responses in sheep cells overexpressing of toll-like receptor 4 when stimulated with LPS," PLoS ONE, vol. 7, no. 10, Article ID e47118, 2012.
19. F. Bihl, L. Salez, M. Beaubier et al., "Overexpression of toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice," The Journal of Immunology, vol. 170, no. 12, pp. 6141-6150, 2003.
20. J. H. Yu andH. Kim, "Oxidative stress and inflammatory signaling in cerulein pancreatitis,"World Journal of Gastroenterology, vol. 20, no. 46, pp. 17324-17329, 2014.
21. I. Gunjaca, J. Zunic, M. Gunjaca, and Z. Kovac, "Circulating cytokine levels in acute pancreatitis - model of SIRS/CARS can help in the clinical assessment of disease severity," Inflammation, vol. 35, no. 2, pp. 758-763, 2012.
22. M. Szajnik, M. J. Szczepanski, M. Czystowska et al., "TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer," Oncogene, vol. 28, no. 49, pp. 4353-4363, 2009.
23. J. Zhao, S. Zhao, G. Zhou et al., "Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis," Scandinavian Journal of Gastroenterology, vol. 46, no. 4, pp. 485-494, 2011.
24. C. De Loera-Rodriguez, V. Delgado-Rizo, A. Alvarado-Navarro, J. Agraz-Cibrian, J. E. Segura-Ortega, and M. Fafutis-Morris, "Over-expression of TLR4-CD14, pro-inflammatory cytokines, metabolic markers and NEFAs in obese non-diabetic Mexicans," Journal of Inflammation, vol. 11, no. 1, p. 39, 2014.
25. X. Wittebole, D. Castanares-Zapatero, and P. F. Laterre, "Tolllike receptor 4 modulation as a strategy to treat sepsis," Mediators of Inflammation, vol. 2010, Article ID 568396, 9 pages, 2010.
26. H. LaRue, C. Ayari, A. Bergeron, and Y. Fradet, "Toll-like receptors in urothelial cells - targets for cancer immunotherapy," Nature Reviews Urology, vol. 10, no. 9, pp. 537-545, 2013.
27. J. J. Kim and D. D. Sears, "TLR4 and insulin resistance," Gastroenterology Research and Practice, vol. 2010, Article ID 212563, 11 pages, 2010.
28. H.-Y. Cho and S. R. Kleeberger, "Genetic mechanisms of susceptibility to oxidative lung injury in mice," Free Radical Biology & Medicine, vol. 42, no. 4, pp. 433-445, 2007.
29. D. Nackiewicz, M. Dan, W. He et al., "TLR2/6 and TLR4- activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6," Diabetologia, vol. 57, no. 8, pp. 1645-1654, 2014.
30. S.-K. Heo, H.-J. Yun, E.-K. Noh, W.-H. Park, and S.-D. Park, "LPS induces inflammatory responses in human aortic vascular smooth muscle cells via Toll-like receptor 4 expression and nitric oxide production," Immunology Letters, vol. 120, no. 1-2, pp. 57-64, 2008.
31. B. S. Taylor, M. E. de Vera, R. W. Ganster et al., "Multiple NF- κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene," The Journal of Biological Chemistry, vol. 273, no. 24, pp. 15148-15156, 1998.
32. A. E. Dikalova, M. C. Góngora, D. G. Harrison, J. D. Lambeth, S. Dikalov, and K. K. Griendling, "Upregulation of Nox1 in vascular smooth muscle leads to impaired endotheliumdependent relaxation via eNOS uncoupling," The American Journal of Physiology:Heart and Circulatory Physiology, vol. 299, no. 3, pp. H673-H679, 2010.
33. N. Xia, A. Daiber, A. Habermeier et al., "Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice," Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 1, pp. 149-154, 2010.
34. B. Gopalakrishnan, K. M. Nash, M. Velayutham, and F. A. Villamena, "Detection of nitric oxide and superoxide radical anion by electron paramagnetic resonance spectroscopy from cells using spin traps," Journal of Visualized Experiments, no. 66, Article ID e2810, 2012.
35. X. Zhang, P. Shan, S. Qureshi et al., "Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury," Journal of Immunology, vol. 175, no. 8, pp. 4834-4838, 2005.
36. A. P. Bautista and J. J. Spitzer, "Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver," The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 266, no. 5, part 1, pp. G783-G788, 1994.
37. W. A. Pryor and G. L. Squadrito, "The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide,"The American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 268, no. 5, pp. L699-L722, 1995.
38. A. L. Moens and D. A. Kass, "Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease," Journal of Cardiovascular Pharmacology, vol. 50, no. 3, pp. 238-246, 2007.
39. T. S. Schmidt, E. McNeill, G. Douglas et al., "Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice," Clinical Science, vol. 119, no. 3, pp. 131-142, 2010.
40. K. Sakai, H. Suzuki, H. Oda et al., "Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage: critical dimerization of inducible nitric-oxide synthase," The Journal of Biological Chemistry, vol. 281, no. 26, pp. 17736-17742, 2006.
41. S. S. Gross and R. Levi, "Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle," Journal of Biological Chemistry, vol. 267, no. 36, pp. 25722-25729, 1992.
42. W. Wang, E. Zolty, S. Falk et al., "Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1," The American Journal of Physiology - Renal Physiology, vol. 294, no. 3, pp. F571-F576, 2008.
43. D. A. Geller, M. di Silvio, T. R. Billiar, and K. Hatakeyama, "GTP cyclohydrolase I is coinduced in hepatocytes stimulated to produce nitric oxide," Biochemical and Biophysical Research Communications, vol. 276, no. 2, pp. 633-641, 2000.
44. S. Cai, N. J. Alp, D. McDonald et al., "GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation," Cardiovascular Research, vol. 55, no. 4, pp. 838-849, 2002.
45. N. J. Alp, S. Mussa, J. Khoo et al., "Tetrahydrobiopterindependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression," The Journal of Clinical Investigation, vol. 112, no. 5, pp. 725-735, 2003.